NASDAQ · RKTOHealthcarePharmaceuticals

Rocket One financials

$0.4422−4.33%
Close Nov 4, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '26
Jun 30
Revenue$0.00
Gross profit$0.00
Gross margin—
Operating income-$3.8M
Net income-$3.8M
Net margin—
Diluted EPS$-0.19
EBITDA-$3.8M
Operating cash flow-$3.0M
Free cash flow-$3.0M
Diluted shares20.5M

Balance sheet

Period endJun 30
Cash & equivalents$7.9M
Short-term investments$0.00
Total debt$0.00
Total assets$9.6M
Total liabilities$1.4M
Shareholders' equity$8.2M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology